Rachel Miller

Rachel Miller, MD, is a Professor in the Department of Obstetrics and Gynecology at the University of Kentucky's Markey Cancer Center, where she specializes in Gynecologic Oncology. She holds affiliate status as a BIRCWH Scholar, supporting interdisciplinary women's health research. Dr. Miller completed her residency at Dartmouth Hitchcock Medical Center and a Gynecologic Oncology fellowship at the University of Kentucky.

Her research focuses on transformative approaches in gynecologic cancer care, including:

• Early detection strategies for ovarian cancer
• Novel therapeutics for advanced ovarian/fallopian tube cancers
• Chemotherapy-induced cognitive impairment
• Robotic and radical pelvic surgical techniques
• Population-based cancer epidemiology
• Surgical education methodologies

She actively develops clinical trials, including establishing the university's intraperitoneal chemotherapy program.

Dr. Miller's publications (2009-2012) demonstrate concentrated focus on ovarian cancer diagnostics and treatment optimization. Key themes include:

• Validation of screening guidelines and multivariate assays
• Long-term survival analysis of ultrasonographically detected cancers
• Risk stratification models for adnexal masses
• Surgical technique refinement and outcome assessment
An early-career paper (2001) additionally reflects interdisciplinary work in glucose-sensing biosensors.

She has received recognition as a BIRCWH Scholar through the Building Interdisciplinary Research Careers in Women's Health program. No student advisees or grant details are documented in available materials.

Dr. Miller contributes to the Gynecologic Oncology research community through the Gynecologic Oncology Group and leads initiatives at the Markey Cancer Center focused on translational cancer studies.